(Q39408153)

English

Inhibition of Gli1 results in altered c-Jun activation, inhibition of cisplatin-induced upregulation of ERCC1, XPD and XRCC1, and inhibition of platinum-DNA adduct repair

scientific article published on 23 January 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Inhibition of Gli1 results in altered c-Jun activation, inhibition of cisplatin-induced upregulation of ERCC1, XPD and XRCC1, and inhibition of platinum-DNA adduct repair (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

1 reference

based on heuristic

inferred from title

author name string

K Kudo

1

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

E Gavin

2

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

S Das

3

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

L Amable

4

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

L A Shevde

5

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

E Reed

6

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

language of work or name

0 references

publication date

23 January 2012

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

31

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

44

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

4718-4724

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

https://scigraph.springernature.com/pub.10.1038/onc.2011.610

0 references

ERCC1 and clinical resistance to platinum-based therapy

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.610

21 January 2018

DNA damage and repair in translational oncology: an overview.

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.610

21 January 2018

Nucleotide excision repair and anti-cancer chemotherapy

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.610

21 January 2018

Platinum-DNA adduct, nucleotide excision repair and platinum based anti-cancer chemotherapy.

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.610

21 January 2018

Cisplatin induction of ERCC-1 mRNA expression in A2780/CP70 human ovarian cancer cells.

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.610

21 January 2018

Modulation of excision repair cross complementation group 1 (ERCC-1) mRNA expression by pharmacological agents in human ovarian carcinoma cells.

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.610

21 January 2018

Phorbol ester exposure activates an AP-1-mediated increase in ERCC-1 messenger RNA expression in human ovarian tumor cells.

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.610

21 January 2018

Cooperation between GLI and JUN enhances transcription of JUN and selected GLI target genes

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.610

21 January 2018

Paracrine Hedgehog signaling in cancer

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.610

21 January 2018

Aberrant activation of hedgehog signaling pathway in ovarian cancers: effect on prognosis, cell invasion and differentiation

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.610

21 January 2018

Role of hedgehog signaling in ovarian cancer

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.610

21 January 2018

Adenoviral delivery of A-FOS, an AP-1 dominant negative, selectively inhibits drug resistance in two human cancer cell lines

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.610

21 January 2018

Acquired cisplatin resistance in human ovarian cancer cells is associated with enhanced repair of cisplatin-DNA lesions and reduced drug accumulation

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.610

21 January 2018

Increased gene-specific repair of cisplatin interstrand cross-links in cisplatin-resistant human ovarian cancer cell lines

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.610

21 January 2018

Thyroid hormone regulates the expression of the sonic hedgehog signaling pathway in the embryonic and adult Mammalian brain

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.610

21 January 2018

Involvement of Hedgehog and FGF signalling in the lamprey telencephalon: evolution of regionalization and dorsoventral patterning of the vertebrate forebrain.

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.610

21 January 2018

Hedgehog overexpression leads to the formation of prostate cancer stem cells with metastatic property irrespective of androgen receptor expression in the mouse model

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.610

21 January 2018

Sonic hedgehog pathway is essential for maintenance of cancer stem-like cells in human gastric cancer

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.610

21 January 2018

Treatment of medulloblastoma with hedgehog pathway inhibitor GDC-0449

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.610

21 January 2018

Inhibition of the hedgehog pathway in advanced basal-cell carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.610

21 January 2018

ERCC1 and ERCC2 expression in malignant tissues from ovarian cancer patients

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.610

21 January 2018

Messenger RNA levels of XPAC and ERCC1 in ovarian cancer tissue correlate with response to platinum-based chemotherapy

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.610

21 January 2018

Gene expression of ERCC1 as a novel prognostic marker in advanced bladder cancer patients receiving cisplatin-based chemotherapy.

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.610

21 January 2018

ERCC1 mRNA levels complement thymidylate synthase mRNA levels in predicting response and survival for gastric cancer patients receiving combination cisplatin and fluorouracil chemotherapy

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.610

21 January 2018

ERCC1 mRNA levels and survival of advanced gastric cancer patients treated with a modified FOLFOX regimen

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.610

21 January 2018

ERCC1 and thymidylate synthase mRNA levels predict survival for colorectal cancer patients receiving combination oxaliplatin and fluorouracil chemotherapy

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.610

21 January 2018

Patients with ERCC1-negative locally advanced esophageal cancers may benefit from preoperative chemoradiotherapy.

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.610

21 January 2018

Catalytic sites for 3' and 5' incision of Escherichia coli nucleotide excision repair are both located in UvrC

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.610

21 January 2018

Molecular cloning of a human DNA repair gene

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.610

21 January 2018

Plant homologue of human excision repair gene ERCC1 points to conservation of DNA repair mechanisms

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.610

21 January 2018

Stimulation of repair replication by 3-aminobenzamide in human fibroblasts with ligase I deficiency

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.610

21 January 2018

The hedgehog pathway transcription factor GLI1 promotes malignant behavior of cancer cells by up-regulating osteopontin

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.610

21 January 2018

Customizing Cisplatin Based on Quantitative Excision Repair Cross-Complementing 1 mRNA Expression: A Phase III Trial in Non–Small-Cell Lung Cancer

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.610

21 January 2018

ERCC1 measurements in clinical oncology

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.610

31 March 2020

Prevention of cisplatin-DNA adduct repair and potentiation of cisplatin-induced apoptosis in ovarian carcinoma cells by proteasome inhibitors

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.610

31 March 2020

Pancreatic cancer--could it be that simple? A different context of vulnerability

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.610

31 March 2020

Single nucleotide polypmorphisms in ERCC1 are associated with disease progression, and survival in patients with advanced stage ovarian and primary peritoneal carcinoma; a Gynecologic Oncology Group study

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.610

31 March 2020

Expression of excision repair genes in non-malignant bone marrow from cancer patients

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.610

31 March 2020

Increased mRNA levels of xeroderma pigmentosum complementation group B (XPB) and Cockayne's syndrome complementation group B (CSB) without increased mRNA levels of multidrug-resistance gene (MDR1) or metallothionein-II (MT-II) in platinum-resistant

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.610

31 March 2020

Identifiers

10.1038/ONC.2011.610

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39408153&oldid=1826306220"